Our previous findings have also demonstrated that nuclear DNM2 overexpression has a considerable relationship with pT stage, grade, and aggressiveness in breast cancer [20] and clear cell renal cell carcinoma [21]. This evidence concerns the gene DNM2 and clear cell renal carcinoma.